Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ·Healthcare·Biotechnology
$283.35
-2.09%
Mkt Cap $40.46B
Analyst Ratings
Buy
18
Hold
4
Sell
0
Price Target (67 analysts)
$460.50
Range $351.00 – $549.00
Implied Upside
+62.5%
Consensus $460.50 vs current $283.35